NEW YORK (GenomeWeb News) – Halo Genomics and Uppsala University today announced a joint project to identify genetic mutations that lead to colon cancer.
The aim of the project, the terms of which were not disclosed, is to develop companion diagnostics that will allow for better individualized treatment of patients with the disease.
Researchers at the university are using Halo's HaloPlex PCR platform to analyze 192 samples from patients with colon cancer and have selected 560 genes to be sequenced for further study. According to Mats Nilsson, who leads a group in the department of immunology, genetics, and pathology at the school, it took one week to prepare the 192 samples for sequencing but no special equipment. Productivity was increased by up to 10 times compared to conventional methods, he said.
The samples are now being sequenced at SciLifeLab, a collaborative Swedish national center comprised of Uppsala, Stockholm University, the Karolinska Institute, and the Royal Institute of Technology.